TSHA
USDTaysha Gene Therapies Inc. Common Stock
Preço em tempo real
Gráfico de preços
Métricas-chave
Métricas de mercado
Abertura
$4.290
Máximo
$4.540
Mínimo
$4.000
Volume
5.02M
Fundamentos da empresa
Capitalização de mercado
1.2B
Setor
Biotecnologia
País
United States
Estatísticas de negociação
Volume médio
6.14M
Bolsa de valores
NMS
Moeda
USD
Faixa de 52 semanas
Notícias relacionadas
Raymond James Initiates Coverage On Taysha Gene Therapies with Strong Buy Rating, Announces Price Target of $13
Raymond James analyst Christopher Raymond initiates coverage on Taysha Gene Therapies with a Strong Buy rating and announces Price Target of $13.
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
DALLAS, Oct. 03, 2025 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (NASDAQ:TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies
Ações relacionadas
CXE
MFS High Income Municipal Trust
VLYPO
Valley National Bancorp 5.50% Fixed-to-Floating Rate Non-Cumulative Perpetual Preferred Stock Series B
EDAP
EDAP TMS S.A. American Depositary Shares
LQR
LQR House Inc.
ALF
Centurion Acquisition Corp. Ordinary Shares
Mantenha-se atualizado
Defina um alerta de preço, obtenha atualizações de análise de IA e notícias de mercado em tempo real.